Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...

The independent journey of German biotech firm CureVac is concluding. Following its acquisition by competitor BioNTech, the ...

ChargePoint Holdings Inc (NYSE: CHPT) shares are trading lower Tuesday, hitting a new all-time low. Here's what you need to ...

Additional information, including the Trust's Monthly and Quarterly Reports, as well as other filings with the SEC can be accessed via the Trust's website at www.ctltrust.net.

According to TheFly on December 5, 2025, Chris Dendrinos, an analyst at RBC Capital, trimmed the price goal for ChargePoint ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...

ChargePoint Holdings, Inc. (CHPT) ended the recent trading session at $7.57, demonstrating a -3.69% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered ...

Our AI models have generated three distinct trading strategies tailored to different risk profiles and holding periods. Each strategy incorporates sophisticated risk management parameters designed to ...

Our AI models have generated three distinct trading strategies tailored to different risk profiles and holding periods. Each strategy incorporates sophisticated risk management parameters designed to ...

As of Tuesday evening Eastern Time, AMD (AMD) shares fell 3.9%, despite the company releasing strong financial results for the third quarter of 2025. Both revenue and adjusted earnings for the quarter ...